University of Helsinki and University of Eastern Finland shareholders in a Finnish COVID vaccine company
|
Category:
News
Rokote Laboratories Finland Ltd., is a newly-founded, Finnish academic spin-out working to develop and introduce to the markets a nasal spray vaccine against COVID. The vaccine is based on research carried out at the University of Helsinki and the University of Eastern Finland.
The founders and board members of the company are the vaccine developers Academy Professor Seppo Ylä-Herttuala from the University of Eastern Finland, Professor Kalle Saksela and Professor Kari Alitalo from the University of Helsinki, and Mr Pasi Kemppainen, MSc (Techn.). The University of Helsinki and the University of Eastern Finland are also co-founders of, and shareholders in, the company.